MYL

Mylan weighs move for Swedish rival Meda

[at Financial Times] – Mylan Inc, the US generic drug producer, is eyeing the takeover of Swedish rival Meda in a deal that would create a $23bn-plus pharmaceuticals business as the US healthcare industry goes through one of … moreView todays social media effects on MYLView the latest stocks trending across Twitter. Click to view dashboardSee who Mylan is hiring […]